SCHEMBL10249889

SCHEMBL10249889

CCNc1c(C(N)=O)cnc(NC)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NNMT P40261 4/20 0.44
JAK2 O60674 3/20 0.40
JAK3 P52333 1/20 0.40
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SYK P43405 6/20 0.36
KCNH2 Q12809 3/20 0.36
ATM Q13315 3/20 0.36
ATR Q13535 2/20 0.36
ZAP70 P43403 1/20 0.36
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
KDR P35968 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
MTOR P42345 1/20 0.35
GSK3B P49841 1/20 0.35
PRKDC P78527 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16440632 0.87 KDM4E (0.36) NNMTJAK2JAK3KDM4EALDH1A1
SCHEMBL2627049 0.72 SYK (0.53) JAK2JAK3SYKZAP70
SCHEMBL28455285 0.70 CYP3A4 (0.40) NNMTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL28777938 0.68 PARP1 (0.51) NNMTJAK2JAK3KDM4EALDH1A1
SCHEMBL27240556 0.67 NNMT (0.46) NNMTJAK2KDM4EALDH1A1SYK
SCHEMBL762022 0.65 SYK (0.52) NNMTSYKZAP70
SCHEMBL20631765 0.65 NNMT (0.47) NNMTJAK2JAK3KDM4EALDH1A1
SCHEMBL4540575 0.65 MKNK1 (0.40) ALDH1A1HSD17B10KCNH2ATMATR
SCHEMBL10250096 0.65 KMT2A (0.35) KDM4EALDH1A1HPGDHSD17B10SIRT2
SCHEMBL13451003 0.65 POLB (0.37) NNMTKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902688-B2 Benzamides and nicotinamides as Syk modulators PORTOLA PHARMACEUTICALS, INC. (US) 2018-02-27 US disclosed
US-20160318852-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS ALEXION PHARMACEUTICALS, INC. 2016-11-03 US disclosed
US-9359375-B2 Benzamides and nicotinamides as Syk modulators PORTOLA PHARMACEUTICALS, INC. (US) 2016-06-07 US disclosed
US-20150038492-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS ALEXION PHARMACEUTICALS, INC. 2015-02-05 US disclosed
US-8846928-B2 Benzamides and nicotinamides as Syk modulators PORTOLA PHARMACEUTICALS, INC. (US) 2014-09-30 US disclosed
US-20120142671-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS PORTOLA PHARMACEUTICALS, INC. (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142671-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS SYK, BTK, NADK NNMT 13/4885JAK2 29/4885JAK3 258/4885
US-20160318852-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS SYK, BTK, NADK NNMT 13/4885JAK2 29/4885JAK3 258/4885
US-20150038492-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS SYK, BTK, NADK NNMT 13/4885JAK2 29/4885JAK3 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.